Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.
about
Effects of Exercise Interventions and Physical Activity Behavior on Cancer Related Cognitive Impairments: A Systematic ReviewClinically Available Medicines Demonstrating Anti-Toxoplasma ActivityCancer-treatment-induced neurotoxicity--focus on newer treatmentsMHC mismatch inhibits neurogenesis and neuron maturation in stem cell allograftsStandard chemoradiation for glioblastoma results in progressive brain volume lossCytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction.Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy.Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?Recapitulating physiological and pathological shear stress and oxygen to model vasculature in health and disease.Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.The chemotherapy agent, thioTEPA, yields long-term impairment of hippocampal cell proliferation and memory deficits but not depression-related behaviors in mice.Prevalence, mechanisms, and management of cancer-related cognitive impairment.Effective inhibition of colon cancer cell growth with MgAl-layered double hydroxide (LDH) loaded 5-FU and PI3K/mTOR dual inhibitor BEZ-235 through apoptotic pathways.Altered small-world properties of gray matter networks in breast cancerGAT: a graph-theoretical analysis toolbox for analyzing between-group differences in large-scale structural and functional brain networksAtypical reversible leucoencephalopathy syndrome after bevacizumab/folfox regimen for metastatic colon cancer.Diffusion tensor MRI of chemotherapy-induced cognitive impairment in non-CNS cancer patients: a review.Systemic chemotherapy decreases brain glucose metabolism.Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions.Pharmacokinetic application of a bio-analytical LC-MS method developed for 5-fluorouracil and methotrexate in mouse plasma, brain and urine.An update on cancer- and chemotherapy-related cognitive dysfunction: current status.Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adultsHerb-drug pharmacokinetic interaction of a traditional chinese medicine jia-wei-xiao-yao-san with 5-Fluorouracil in the blood and brain of rat using microdialysis.Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesisEffects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in miceEffect of neoadjuvant chemotherapy on sevoflurane MAC-BAR value of patients undergoing radical stomach carcinoma surgery.Oculomotor Deficits after Chemotherapy in ChildhoodCanertinib induces ototoxicity in three preclinical models.Why, After Chemotherapy, is it Necessary to Assess Memory Using Translational Testing?Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?Chemotherapy and dietary phytochemical agents.Capecitabine Induced Multifocal Leukoencephalopathy: Do We Have Always to Switch off the Chemotherapy?How chemotherapy damages the central nervous systemNeurological complications following treatment of children with brain tumors.Capecitabine-induced leukoencephalopathy involving the bilateral corticospinal tractsEffects of 5-fluorouracil chemotherapy on fatigue: role of MCP-1.Sex-specific effects of cytotoxic chemotherapy agents cyclophosphamide and mitomycin C on gene expression, oxidative DNA damage, and epigenetic alterations in the prefrontal cortex and hippocampus - an aging connectionEstablishing a model for assessing DNA damage in murine brain cells as a molecular marker of chemotherapy-associated cognitive impairment.MEK1/2 inhibition suppresses tamoxifen toxicity on CNS glial progenitor cells.Synergetic effect of SLN-curcumin and LDH-5-Fu on SMMC-7721 liver cancer cell line
P2860
Q26752851-DD57EBA8-6B78-46E7-9DAC-409EB33A33D4Q26782581-3C91A5D7-7AC0-4820-94F2-D956F8C6FD3FQ26782604-55144647-B3B1-4108-8D97-3C8C296A87FCQ27313884-2FC24646-5CD7-4F31-92CD-00C0C2105440Q27348869-37259141-6220-4E43-8476-A96F2938F3B6Q30390049-F79B9163-1D41-474D-B19A-D3AA53DF8209Q30499383-4BBD9269-2E31-45A1-95A9-A5C33437A1DAQ31155370-A2B937C0-AA62-4229-A1FE-A5B34D088740Q33600738-5B238E06-93C6-4B2D-BD80-B565F72DE833Q33684453-323DB3B5-5901-4233-830E-E2B38CE80E76Q33703348-54E28E39-B5A1-4CE2-90D2-A423EC7C66E0Q33854977-58B79088-E89C-4D1A-9154-7EDE7D443B24Q33934922-89FB3874-2A12-478B-A228-02A72B6768E1Q34282795-F2EA8B31-94C1-43CF-8F99-410019DE1E60Q34342306-2B4492A7-1AE6-4F44-9A12-596D720589D6Q34461277-D4607A64-26D3-4041-9881-173811E02E5DQ34553351-7C1DD02B-F511-4048-AF78-216E6EDCF920Q34562855-6B57115E-F06C-4D80-BA11-3B0C3CFA1F4CQ34604438-40A8CF67-DD7B-4103-A241-53DA78631514Q34620942-322F3EE7-86C5-4A18-8765-CA7D0DCB4EA6Q35059702-E66D1ACF-62DF-456F-9019-1252BC70DE37Q35164117-6E20737A-C2EB-45FB-84A1-76105971C20BQ35226944-5B105C8D-FF21-4379-BA8B-2818793F3243Q35566553-E9DDFC34-398F-4FC6-B555-2E320C8ECAC8Q35644334-78C63A36-324D-43ED-9723-19D2DCE6A645Q35791400-86F5723B-BF6B-4322-9C10-BC21EB1E62A7Q35905646-7D73DAD9-80A4-4A84-8CA0-1B4B388224A7Q36088986-0E8CB676-530E-44D0-A833-3EBBF2A0FBA5Q36440620-A8EEA678-2A62-4011-87D8-E8AE6B4CADD3Q36468050-05499F3E-ACF2-4A25-8354-703D0359AD0DQ36516033-F00858E4-5BAC-4977-B092-33FC3C725C14Q36600571-FC31F520-A147-405E-BD66-EB93142F6373Q36678547-AFD3BCAF-F828-4A3E-907E-F208E0E46FA9Q36729469-29CC2B9E-8688-4A56-B02C-C850A930C418Q36885192-2CDC2017-847F-4D10-B9AD-1493A66A7518Q37012199-512AB8C9-3CC6-4F58-BC65-35D15B701C37Q37049097-F856F6E9-6BF8-42D6-A254-E125BFE0B999Q37107037-665D93ED-6E18-4CF3-A313-C42E3B7008D1Q37179748-3D55810C-35D9-499F-BAA7-231905EA7DB2Q37183891-253371E6-2FF2-4B3A-8F2D-92A760E81572
P2860
Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Systemic 5-fluorouracil treatm ...... in the central nervous system
@nl
Systemic 5-fluorouracil treatm ...... in the central nervous system.
@ast
Systemic 5-fluorouracil treatm ...... in the central nervous system.
@en
Systemic 5-fluorouracil treatm ...... in the central nervous system.
@en-gb
type
label
Systemic 5-fluorouracil treatm ...... in the central nervous system
@nl
Systemic 5-fluorouracil treatm ...... in the central nervous system.
@ast
Systemic 5-fluorouracil treatm ...... in the central nervous system.
@en
Systemic 5-fluorouracil treatm ...... in the central nervous system.
@en-gb
prefLabel
Systemic 5-fluorouracil treatm ...... in the central nervous system
@nl
Systemic 5-fluorouracil treatm ...... in the central nervous system.
@ast
Systemic 5-fluorouracil treatm ...... in the central nervous system.
@en
Systemic 5-fluorouracil treatm ...... in the central nervous system.
@en-gb
P2093
P2860
P3181
P356
P1433
P1476
Systemic 5-fluorouracil treatm ...... in the central nervous system.
@en
P2093
Joerg Dietrich
Margot Mayer-Pröschel
Mark Noble
Yin M Yang
P2860
P2888
P3181
P356
10.1186/JBIOL69
P407
P577
2008-04-22T00:00:00Z
P5875
P6179
1005223943